Detalhe da pesquisa
1.
Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
Blood
; 142(15): 1281-1296, 2023 10 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37478401
2.
Spontaneous resolution of severe idiopathic T cell lymphopenia.
Clin Immunol
; 238: 109014, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35447312
3.
B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation.
Blood
; 131(26): 2967-2977, 2018 06 28.
Artigo
Inglês
| MEDLINE | ID: mdl-29728406
4.
Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD.
Blood
; 127(5): 646-57, 2016 Feb 04.
Artigo
Inglês
| MEDLINE | ID: mdl-26670634
5.
Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease.
Blood
; 128(1): 130-7, 2016 07 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27073224
6.
Combined immunodeficiency with EBV positive B cell lymphoma and epidermodysplasia verruciformis due to a novel homozygous mutation in RASGRP1.
Clin Immunol
; 183: 142-144, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28822832
7.
Leukocyte protease binding to nucleic acids promotes nuclear localization and cleavage of nucleic acid binding proteins.
J Immunol
; 192(11): 5390-7, 2014 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24771851
8.
Immunologic reconstitution following hematopoietic stem cell transplantation despite lymph node paucity in NF-κB-inducing kinase deficiency.
J Allergy Clin Immunol
; 143(3): 1240-1243.e4, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30445060
9.
Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma.
Cancer Cell
; 9(5): 405-16, 2006 May.
Artigo
Inglês
| MEDLINE | ID: mdl-16697960
10.
Tabelecleucel for EBV+ PTLD following allogeneic HCT or SOT in a multicenter expanded access protocol.
Blood Adv
; 2024 Apr 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38625984
11.
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment.
Nat Commun
; 15(1): 3258, 2024 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38637498
12.
The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.
Biol Blood Marrow Transplant
; 24(7): 1322-1340, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29471034
13.
Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation.
Clin Case Rep
; 11(11): e8190, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-38028059
14.
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease.
Blood Adv
; 7(16): 4647-4657, 2023 08 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37603347
15.
Inefficiency of two-stage designs in phase II oncology clinical trials with high proportion of inevaluable patients.
Contemp Clin Trials
; 120: 106849, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35868503
16.
Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients with refractory chronic graft-versus-host disease.
Front Immunol
; 13: 954966, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36189229
17.
Genetic diagnosis of immune dysregulation can lead to targeted therapy for interstitial lung disease: A case series and single center approach.
Pediatr Pulmonol
; 57(7): 1577-1587, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35426264
18.
Comparison of Pulmonary Toxicity after Total Body Irradiation- and Busulfan-Based Myeloablative Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients.
Transplant Cell Ther
; 28(8): 502.e1-502.e12, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35623615
19.
Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host disease.
Blood Adv
; 6(15): 4392-4402, 2022 08 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35617682
20.
A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease.
Blood Adv
; 6(21): 5786-5796, 2022 11 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35475885